Jenburkt Pharmaceuticals Ltd reports jump in Q2FY22 PAT to Rs. 7.97 crore

The Board of Directors of JENBURKT PHARMACEUTICALS LTD., at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.

For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 36.6990 crore, against ₹31.5073 crore in the corresponding quarter of the previous year (YoY) and ₹28.3747 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹7.9704 crore, against ₹5.6720 crore in the corresponding quarter of the previous year (YoY) and ₹4.6509 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹17.37, against ₹12.36 in the corresponding quarter of the previous year (YoY) and ₹10.13 in previous quarter (QoQ).

Financials	Q2 FY2022	Q1 FY2022	QoQ % Change	Q2 FY2021	YoY % Change
Total Income	₹ 36.6990 crs	₹28.3747 crs	29.34%	₹31.5073 crs	16.48%
Net Profit	₹7.9704 crs	₹4.6509 crs	71.37%	₹5.6720 crs	40.52 %
EPS	₹17.37	₹10.13	71.47%	₹12.36	40.53%

For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹65.0737 crore, against ₹49.9144 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit / (loss) was at ₹12.6213 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹6.68 crore in the previous year (YoY) (Half Year Ended FY 2021).

The Earnings Per Share stood at ₹27.50 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹14.56 in the previous year (YoY) (Half Year Ended FY 2021).

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹65.0737 crs	₹49.9144 crs	30.37%
Net Profit	₹12.6213 crs	₹6.68 crs	88.94%
EPS	₹27.50	₹14.56	88.87%

Shares of JENBURKT PHARMACEUTICALS LTD. was last trading in BSE at Rs. 481.95 as compared to the previous close of Rs. 472.90. The total number of shares traded during the day was 3900 in over 60 trades.

The stock hit an intraday high of Rs. 489.50 and intraday low of 462.00. The net turnover during the day was Rs. 1872179.00.

Source : Equity Bulls

Keywords

JenburktPharmaceuticals Q2FY22 H1FY22 ResultUpdate